X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3125) 3125
Book Review (675) 675
Publication (268) 268
Book Chapter (9) 9
Conference Proceeding (9) 9
Web Resource (2) 2
Dissertation (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (2562) 2562
humans (2485) 2485
chronic myelogenous leukemia (1581) 1581
hematology (1539) 1539
oncology (1257) 1257
male (1242) 1242
female (1203) 1203
middle aged (1112) 1112
adult (1093) 1093
chronic myeloid leukemia (1038) 1038
chronic-phase (1015) 1015
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (1015) 1015
imatinib mesylate (995) 995
chronic myeloid-leukemia (961) 961
chronic phase (833) 833
imatinib (754) 754
pyrimidines - therapeutic use (741) 741
aged (731) 731
antineoplastic agents - therapeutic use (720) 720
benzamides (685) 685
piperazines - therapeutic use (621) 621
treatment outcome (619) 619
leukemia, myelogenous, chronic, bcr-abl positive - genetics (595) 595
protein kinase inhibitors - therapeutic use (558) 558
leukemia, myeloid, chronic-phase - drug therapy (517) 517
cml (513) 513
adolescent (500) 500
dasatinib (492) 492
fusion proteins, bcr-abl - genetics (473) 473
bcr-abl (467) 467
interferon-alpha (426) 426
leukemia, myelogenous, chronic, bcr-abl positive - pathology (419) 419
leukemia (418) 418
leukemia, myelogenous, chronic, bcr-abl positive - therapy (405) 405
therapy (390) 390
follow-up (385) 385
tyrosine kinase inhibitors (356) 356
abridged index medicus (353) 353
prognosis (333) 333
nilotinib (328) 328
protein-tyrosine kinases - antagonists & inhibitors (321) 321
philadelphia-chromosome (308) 308
young adult (303) 303
leukemia, myeloid, chronic-phase - genetics (293) 293
aged, 80 and over (281) 281
cancer (280) 280
transplantation (272) 272
hemic and lymphatic diseases (271) 271
tyrosine kinase inhibitor (271) 271
care and treatment (270) 270
blast crisis (269) 269
animals (263) 263
leukemia, myelogenous, chronic, bcr-abl positive - mortality (251) 251
pyrimidines - adverse effects (250) 250
cytogenetic responses (247) 247
leukemia, myeloid, chronic-phase - pathology (243) 243
pyrimidines - administration & dosage (242) 242
follow-up studies (239) 239
survival (238) 238
drug resistance, neoplasm (228) 228
research (226) 226
acute lymphoblastic-leukemia (213) 213
leukemia, myelogenous, chronic, bcr-abl positive - diagnosis (212) 212
interferon (211) 211
transplantation, homologous (207) 207
remission induction (206) 206
mutation (205) 205
retrospective studies (203) 203
antineoplastic agents - adverse effects (202) 202
time factors (202) 202
antineoplastic agents - administration & dosage (200) 200
tyrosine kinase (199) 199
philadelphia chromosome (196) 196
tyrosine (196) 196
immunology (195) 195
resistance (195) 195
analysis (194) 194
drug therapy (192) 192
child (191) 191
hematology, oncology and palliative medicine (191) 191
survival analysis (191) 191
pharmacology & pharmacy (188) 188
bone-marrow transplantation (187) 187
bone marrow transplantation (183) 183
piperazines - administration & dosage (182) 182
survival rate (182) 182
piperazines - adverse effects (174) 174
pyrimidines - pharmacology (174) 174
interferon-alpha - therapeutic use (173) 173
protein kinase inhibitors - adverse effects (169) 169
leukemia, myeloid, chronic-phase - therapy (167) 167
diagnosed chronic-phase (166) 166
disease-free survival (166) 166
medicine & public health (166) 166
leukemia, myeloid, chronic-phase - mortality (165) 165
protein kinase inhibitors - administration & dosage (163) 163
thiazoles - therapeutic use (163) 163
antineoplastic combined chemotherapy protocols - therapeutic use (161) 161
mice (160) 160
cytogenetic response (158) 158
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2927) 2927
Japanese (63) 63
Chinese (30) 30
German (30) 30
Spanish (28) 28
French (20) 20
Russian (19) 19
Portuguese (12) 12
Polish (5) 5
Turkish (3) 3
Czech (2) 2
Italian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


10/2009
This study investigated whether a long-term high-fat diet has an effect on the outcome of chronic murine schistosomiasis mansoni compared to a standard diet.... 
Schistosoma mansoni - cholesterol - chronic phase
Web Resource
HAEMATOLOGICA, ISSN 0390-6078, 06/2019, Volume 104, Issue 7, pp. e293 - e295
Journal Article
LEUKEMIA RESEARCH, ISSN 0145-2126, 10/2018, Volume 73, pp. S6 - S7
Conference Proceeding
The Oncologist, ISSN 1083-7159, 09/2019, Volume 24, Issue 9, pp. 1253 - 1258
Tyrosine kinase inhibitors (TKI) have greatly improved survival for patients diagnosed with chronic myeloid leukemia. It has been shown that patients with a... 
Polypharmacy | Myeloid | Goals | Decision making | Leukemia | Chronic phase
Journal Article
01/2012
The pathogenesis and evolutive pattern of Chagas disease suggests that the chronic phase should be more widely treated in order to (i) eliminate Trypanosoma... 
Chagas disease | chronic phase | combination of drugs | repeated treatment | chemotherapy | new strategies
Web Resource
Journal of Clinical Oncology, ISSN 0732-183X, 09/2018, Volume 36, Issue 25, pp. 2657 - 2658
Journal Article
Haematologica, ISSN 0390-6078, 01/2019, Volume 104, Issue 1, pp. 93 - 101
Dasatinib, a second-generation BCR-ABL1 tyrosine kinase inhibitor, is approved for the treatment of chronic myeloid leukemia and Philadelphia... 
CYTOGENETIC RESPONSES | IMATINIB-RESISTANT | INTOLERANT CHRONIC-PHASE | INHIBITION | EFFICACY | TOLERABILITY | FOLLOW-UP | HEMATOLOGY | FAILURE | CHRONIC MYELOID-LEUKEMIA
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2013, Volume 369, Issue 19, pp. 1783 - 1796
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 12/2009, Volume 15, Issue 24, pp. 7519 - 7527
Targeted therapy in the form of selective tyrosine kinase inhibitors (TKI) has transformed the approach to management of chronic myeloid leukemia (CML) and... 
CHRONIC MYELOGENOUS LEUKEMIA | PHILADELPHIA-POSITIVE PATIENTS | STEM-CELLS | MAJOR MOLECULAR RESPONSES | CHRONIC-PHASE | ONCOLOGY | KINASE DOMAIN MUTATIONS | CYTOGENETIC CLONAL EVOLUTION | BCR-ABL MUTATIONS | MULTIDRUG-RESISTANCE | GIMEMA WORKING PARTY
Journal Article
World Neurosurgery, ISSN 1878-8750, 06/2019, Volume 126, pp. e385 - e391
The angioarchitecture of the spinal cord and microvascular changes after acute and subacute spinal cord injury (SCI) have been reported in rodents.... 
Hemicontusion | Microvasculature | Three-dimensional | Spinal cord injury | Chronic phase | Earthquakes | Spinal cord injuries
Journal Article
Blood, ISSN 0006-4971, 02/2012, Volume 119, Issue 5, pp. 1123 - 1129
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2017, Volume 35, Issue 5, pp. 567 - 568
Journal Article
Journal Article
HAEMATOLOGICA, ISSN 0390-6078, 04/2019, Volume 104, Issue 5, pp. 955 - 962
Standard first-line therapy of chronic myeloid leukemia is treatment with imatinib. In the randomized German Chronic Myeloid Leukemia-Study IV, more potent... 
CHRONIC MYELOGENOUS LEUKEMIA | SURVIVAL